Published in JAMA on November 05, 1997
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol (2015) 3.64
How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst (2014) 3.43
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst (2008) 2.69
Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology (2009) 2.57
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst (2003) 2.11
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol (2008) 1.88
Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res (2004) 1.85
Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.67
Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol (2010) 1.66
Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med (2009) 1.57
Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol (2011) 1.56
Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol (2010) 1.56
Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst (2009) 1.47
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One (2012) 1.43
Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer (2001) 1.41
Weight gain prevention among women. Obesity (Silver Spring) (2007) 1.36
Oestrogen exposure and breast cancer risk. Breast Cancer Res (2003) 1.34
Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer (2015) 1.32
Results of a faith-based weight loss intervention for black women. J Natl Med Assoc (2005) 1.30
Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res (2008) 1.28
Validation of self-reported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause (2009) 1.27
Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol Endocrinol (2012) 1.27
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat (2011) 1.24
Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer (2005) 1.22
Belief in numbers: When and why women disbelieve tailored breast cancer risk statistics. Patient Educ Couns (2013) 1.20
Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res (2003) 1.19
Weight at birth and adolescence and premenopausal breast cancer risk in a low-risk population. Br J Cancer (2002) 1.19
Breast and colorectal cancer risk communication approaches with low-income African-American and Hispanic women: implications for healthcare providers. J Natl Med Assoc (2004) 1.19
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev (2014) 1.17
Estrogen and xenoestrogens in breast cancer. Toxicol Pathol (2009) 1.17
Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer (1999) 1.17
Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk? J Gen Intern Med (2004) 1.13
Physical activity patterns and prevention of weight gain in premenopausal women. Int J Obes (Lond) (2009) 1.12
The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet (2011) 1.12
Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab (2011) 1.12
Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc (2006) 1.10
Breast cancer risk-assessment models. Breast Cancer Res (2007) 1.09
Body mass index in young adulthood and cancer mortality: a retrospective cohort study. J Epidemiol Community Health (2002) 1.09
The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia (2007) 1.08
Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol (2007) 1.06
Criteria for the evaluation of large cohort studies: an application to the nurses' health study. J Natl Cancer Inst (2008) 1.06
The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control (2012) 1.05
Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer (2008) 1.03
Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.03
Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer (2012) 1.02
Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Res (2010) 1.02
Lifetime exercise activity and breast cancer risk among post-menopausal women. Br J Cancer (1999) 1.01
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPAR Res (2009) 1.01
Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev (2013) 0.99
Screening for Cushing's syndrome in obese patients. Clinics (Sao Paulo) (2010) 0.99
Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res (2008) 0.99
Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk. Obes Facts (2009) 0.99
Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst (2010) 0.99
Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol (2014) 0.98
Influence of prediagnostic recreational physical activity on survival from breast cancer. Eur J Cancer Prev (2012) 0.97
The role of adiponectin in breast cancer: a meta-analysis. PLoS One (2013) 0.96
Adult weight change and incidence of premenopausal breast cancer. Int J Cancer (2011) 0.96
Breast Cancer Research in the Nurses' Health Studies: Exposures Across the Life Course. Am J Public Health (2016) 0.96
Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study. BMC Cancer (2009) 0.96
Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2005) 0.95
25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat (2012) 0.94
Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med (2016) 0.94
Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis. Int J Breast Cancer (2014) 0.93
Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight. Br J Cancer (2000) 0.93
Trajectory of body shape across the lifespan and cancer risk. Int J Cancer (2016) 0.93
Body size and breast cancer in a black population--the Barbados National Cancer Study. Cancer Causes Control (2008) 0.93
Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality. Int J Cancer (2014) 0.92
Solid tumor second primary neoplasms: who is at risk, what can we do? Semin Oncol (2013) 0.92
Weight control needs and experiences among rural breast cancer survivors. Psychooncology (2010) 0.92
Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res (2015) 0.92
Does diet affect breast cancer risk? Breast Cancer Res (2004) 0.91
An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk. Comput Math Methods Med (2012) 0.91
Tracking progesterone receptor-mediated actions in breast cancer. Pharmacol Ther (2013) 0.91
Birth weight in relation to endometrial and breast cancer risks in Swedish women. Br J Cancer (2006) 0.90
Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev (2014) 0.90
Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk. Mol Biol Rep (2011) 0.89
Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res (Phila) (2011) 0.89
Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations. J Cancer Epidemiol (2009) 0.89
Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women. J Carcinog (2006) 0.88
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. PLoS Med (2016) 0.87
Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev (2014) 0.87
Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative. Breast Cancer Res Treat (2013) 0.86
Risk factors for breast cancer and expression of insulin-like growth factor-2 (IGF-2) in women with breast cancer in Wuhan City, China. PLoS One (2012) 0.86
Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Springerplus (2013) 0.86
Lifetime physical activity and risk of breast cancer. Br J Cancer (2001) 0.86
A developmental hypothesis to explain the multicentricity of breast cancer. CMAJ (1998) 0.85
Urban-rural differences in a population-based breast cancer screening program in Croatia. Croat Med J (2011) 0.84
Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women. Breast Cancer Res Treat (2013) 0.84
Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women. Eur J Cancer Prev (2013) 0.84
A reduced-calorie dietary pattern including a daily sweet snack promotes body weight reduction and body composition improvements in premenopausal women who are overweight and obese: a pilot study. J Am Diet Assoc (2011) 0.83
Weight change in adulthood and risk of postmenopausal breast cancer: the HUNT study of Norway. Br J Cancer (2013) 0.82
Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years. Cancer (2014) 0.82
Body size in relation to urinary estrogens and estrogen metabolites (EM) among premenopausal women during the luteal phase. Horm Cancer (2012) 0.81
Short-term weight gain and breast cancer risk by hormone receptor classification among pre- and postmenopausal women. Breast Cancer Res Treat (2015) 0.81
Physical activity in first-degree relatives of breast cancer patients. J Behav Med (2001) 0.81
Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front Biosci (2007) 0.80
An association between air pollution and mortality in six U.S. cities. N Engl J Med (1993) 38.84
Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med (1995) 15.80
Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Body weight and mortality among women. N Engl J Med (1995) 11.04
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98
Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84
Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28
Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05
Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98
No hiding place: on the discomforts of researching the contemporary policy process. J Soc Policy (1990) 8.97
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Test of the National Death Index. Am J Epidemiol (1984) 8.46
Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43